1) There is a need for equitable access to quality healthcare in emerging markets, including affordable essential care and treatment for diseases like diabetes, cardiovascular issues, and infectious diseases.
2) Emerging markets represent a major commercial opportunity for pharmaceutical companies, with industry forecasts showing 12% annual growth and emerging markets making up 30-50% of global pharmaceutical sales by 2020.
3) However, there are challenges to addressing healthcare needs and realizing commercial opportunities in emerging markets, including issues around access, reimbursement, intellectual property protection, and corruption.
![Need ,[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)